The pleiotropic movement disorders phenotype of adult ataxia-telangiectasia

Aurélie Méneret(Centre National de la Recherche Scientifique), Yara Ahmar-Beaugendre(Centre National de la Recherche Scientifique), Guillaume Rieunier(Centre National de la Recherche Scientifique), Nizar Mahlaoui(Centre National de la Recherche Scientifique), Bertrand Gaymard(Centre National de la Recherche Scientifique), Emmanuelle Apartis(Centre National de la Recherche Scientifique), Christine Tranchant(Centre National de la Recherche Scientifique), Sophie Rivaud-Péchoux(Centre National de la Recherche Scientifique), Bertrand Degos(Centre National de la Recherche Scientifique), B Benyahia(Centre National de la Recherche Scientifique), Felipe Suárez(Centre National de la Recherche Scientifique), Thierry Maisonobe(Centre National de la Recherche Scientifique), Michel Kœnig(Centre National de la Recherche Scientifique), Alexandra Dürr(Centre National de la Recherche Scientifique), Marc‐Henri Stern(Centre National de la Recherche Scientifique), Catherine Dubois d’Enghien(Centre National de la Recherche Scientifique), Alain Fischer(Centre National de la Recherche Scientifique), Marie Vidailhet(Centre National de la Recherche Scientifique), Dominique Stoppa-Lyonnet(Centre National de la Recherche Scientifique), David Grabli(Centre National de la Recherche Scientifique), Mathieu Anheim(Centre National de la Recherche Scientifique)
Neurology
August 14, 2014
Cited by 76

Abstract

OBJECTIVE: To assess the clinical spectrum of ataxia-telangiectasia (A-T) in adults, with a focus on movement disorders. METHODS: A total of 14 consecutive adults with A-T were included at 2 tertiary adult movement disorders centers and compared to 53 typical patients with A-T. Clinical evaluation, neurophysiologic and video-oculographic recording, imaging, laboratory investigations, and ATM analysis were performed. RESULTS: In comparison with typical A-T cases, our patients demonstrated later mean age at onset (6.1 vs 2.5 years, p < 0.0001), later loss of walking ability (p = 0.003), and longer survival (p = 0.0039). The presenting feature was ataxia in 71% and dysarthria and dystonia in 14% each. All patients displayed movement disorders, among which dystonia and subcortical myoclonus were the most common (86%), followed by tremor (43%). Video-oculographic recordings revealed mostly dysmetric saccades and 46% of patients had normal latencies (i.e., no oculomotor apraxia) and velocities. The α-fetoprotein (AFP) level was normal in 7%, chromosomal instability was found in 29% (vs 100% of typical patients, p = 0.0006), and immunoglobulin deficiency was found in 29% (vs 69%, p = 0.057). All patients exhibited 2 ATM mutations, including at least 1 missense mutation in 79% of them (vs 36%, p = 0.0067). CONCLUSION: There is great variability of phenotype and severity in A-T, including a wide spectrum of movement disorders. Karyotype and repeated AFP level assessments should be performed in adults with unexplained movement disorders as valuable clues towards the diagnosis. In case of a compatible phenotype, A-T should be considered even if age at onset is late and progression is slow.


Related Papers

No related papers found

Powered by citation graph analysis